24 devices · GMDN 62843
This category includes in vitro diagnostic devices that use antibodies to detect delta-catenin, a protein involved in cell adhesion and signaling, in clinical specimens such as tissue or blood samples. These tests are designed to support the qualitative or quantitative assessment of delta-catenin levels, which may aid in research or clinical evaluation of conditions where this biomarker is relevant, such as certain cancers or neurological disorders.
Devices in this category are immunological assays that rely on specific antibody-antigen binding and are regulated as in vitro diagnostics. They are intended for use in laboratory settings by trained professionals and are supplied as reagents or test kits, with their regulatory status determined by the intended use and jurisdiction in which they are marketed.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.